Aspirin

Producers shown on SFDA

(Record date:30/08/2021）

Producers shown on EP

Not showing any

Producer:Hebei Jingye Pharmaceutical Technology Co., Ltd. is a pharmaceutical high-tech enterprise based in China and facing the world. The company is committed to growing into a manufacturer of high-quality salicylic acid and aspirin, focusing on the manufacturing, R & D and service of cardiovascular and cerebrovascular preparations and API. There are 4 product varieties and 6 reserve varieties, all of which are preparations and APIs in the field of cardio cerebrovascular with broad development prospects.

The design capacity is 20000 t / A for pharmaceutical intermediate salicylic acid, 3000 t / A for sodium salicylate, 2000 t / A for API salicylic acid and 8000 T / A for aspirin, 1.5 billion tablets and 150 million injections. The project is constructed in three phases, including production area, production auxiliary area, office and living area and public works area.

Staff size:300-399 persons

Registered capital:RMB 20.6 million

Producer:JQC(Huayin) Pharmaceutical Co., Ltd. is a private enterprise reorganized by purchasing part of its land and ground assets during the bankruptcy and reorganization of the second synthetic pharmaceutical factory in Northwest China, a former large state-owned pharmaceutical enterprise. It is a pharmaceutical enterprise specializing in the R & D and production of APIs and chemical intermediates, focusing on the production and R & D of salicylic acid series products, The registered capital is 11.18 million yuan, and the actual capital is nearly 150 million yuan.

At the end of 2004, it passed the GMP certification of the pharmaceutical industry of China's State Food and drug administration, and has the right of self import and export. It passed the audit of the U.S. FDA on January 26, 2013. We have registered the NDC number of export products in Deng Baishi. At present, we are actively preparing to submit DMF, cos, reach and other relevant documents of various products to the United States, Europe and other relevant countries and regions. 75% of the annual sales value of 150 million yuan is exported to the international market. The company has its own property rights, land area of 17645 square meters, total construction area of more than 7700 square meters and green area of more than 2500 square meters. It has its own R & D and production base, 5 sets of independent API 100000 purification production lines (4 solid lines and 1 liquid line) built in accordance with GMP standards, complete supporting facilities and abundant water, electricity and gas resources.

Staff size:RMB 11.18 million

Registered capital:200-299 persons

Producer:Hubei Hope Pharmaceutical Co., Ltd., established in 2002, is a modern pharmaceutical enterprise specializing in the development, production and sales of antibiotics, antiviral drugs, digestive drugs, antipyretic and analgesic drugs and disinfection products. The company covers an area of 45000 square meters, with a registered capital of 30 million yuan and total assets of more than 100 million yuan
At present, the company has chemical synthesis production line, general API production line, sterile API production line, sterile lyophilized preparation production line, sterile powder injection production line, disinfectant production workshop and disinfection equipment production workshop in line with the national GMP specification. More than 20 kinds of products are produced throughout the year, which are sold all over the country and have been highly praised by consumers.

Staff size:About 50-99 persons

Registered capital:RMB 30 million

Producer:Jilin Jinheng Pharmaceutical Co., Ltd., established in April 2003, is a large comprehensive pharmaceutical group integrating API, bioengineering pharmacy, western medicine, Chinese patent medicine, health products and pharmaceutical intermediates.

Jilin Hengjin Pharmaceutical Co., Ltd. is a key high-tech enterprise recognized by the state, with independent import and export management rights. At present, there are 343 kinds of preparation products and 23 varieties of synthetic drugs. It has many modern production lines such as solid preparations, oral liquid, powder injection, water injection and chemical API, all of which have passed the national GMP certification.

Staff size:200-299 persons

Registered capital:RMB 16.25 million

Producer:Shandong Xinhua Pharmaceutical Co., Ltd., established in Jiaodong Anti Japanese base in 1943, is the first chemical synthetic pharmaceutical enterprise in China, an important global production and export base of antipyretic and analgesic drugs, and an important domestic manufacturer of cardio cerebrovascular, anti infection and central nervous system. It has three pillar industries of chemical raw materials, pharmaceutical preparations and pharmaceutical intermediates, five industrial parks and 13 subsidiaries. The annual production capacity of chemical APIs is 40000 tons, pharmaceutical intermediates is 500000 tons, solid preparations are 28 billion tablets (tablets), and injections are 1 billion.

At present, all the drugs in production of Xinhua Pharmaceutical have passed the new national GMP certification, 18 products have passed the FDA inspection, 10 products have obtained the EU cos certificate, and the tablets have passed the MHRA audit of the UK drug and health products administration. More than 3 billion tablets have been exported to the EU high-end market, It has become one of the first 15 leading enterprises implementing the internationalization strategy of preparations in China and one of the top ten enterprises in the export of preparations in China.

Staff size:About 7000 persons

Registered capital:RMB 627 million 400 thousand

Producer:Reyoung Pharmaceutical Co., Ltd., established in 1966, is a modern comprehensive pharmaceutical company. Reyoung is given the title of National Trustworthy Company for Contract and Credit, Grade AAA Credit Company and Credit Company of Shandong Medical Industry. In the past 50 years, Reyoung inherits the mission “Reyoung Pharma., Benefit the public”, insists the business concept “Innovation is the basis, Product quality is first”. Never stop exploration and innovation, forging ahead with determination, and realizing the sustainable healthy development. Now Reyoung consists of 3 factory sites (covering an area of 1 million m2), possessing more than more than 30 workshops (9 categories, and 400 strengths) focusing on developing, manufacturing and selling Powder for Injection (including Lyophilized Powder for Injection), Small Volume Injection, Traditional Chinese Medicine, Tablets, Capsules, Granules, Suppository, Mixtures and APIs. All the workshops have been passed the cGMP. Reyoung also pass ISO system certificates. Reyoung also passed the oversea audit like PIC/S GMP.

Staff size:About 4000 persons

Registered capital:RMB 366.74 million

Producer:Hunan Middle－south Pharmaceutical Co., Ltd.is a private pharmaceutical enterprise restructured from the former Zhongnan pharmaceutical factory. It is a key backbone enterprise in the national pharmaceutical industry and one of the national bases for the production of chemical synthetic drugs. It has a solid preparation workshop certified by the national drug GMP, aspirin, olamit, pentafluorolido API and other production workshops. The company occupies an area of more than 190000 square meters and has total assets of 130 million yuan.

The preparation workshop has an annual production capacity of 1 billion tablets,   It has developed into a comprehensive enterprise integrating R & D, production and sales of APIs, preparations and pharmaceutical intermediates.

Staff size:About 50 persons

Registered capital:RMB 96.68 million

Producer:Chifeng Wanze Pharmaceutical Co., Ltd. is located at No. 3 Wanze Avenue, Hongshan high tech Industrial Development Zone, Chifeng City, covering an area of 84000 square meters. The company has 85 varieties of chemical raw materials, tablets, capsules, granules, ointments, creams, solutions and liniments. The company has several modern product lines and took the lead in passing the new version (2010 version) GMP certification in Inner Mongolia Autonomous Region in August 2014. The export products of main preparations meet BP and USP standards; The quality of some APIs has reached the original research standard. Foreign trade products are exported to Japan, South Korea, South America, Africa and other countries and regions.

Staff size:100-199 persons

Registered capital:RMB 50 million